RivatigTM

Rivastigmine
Anti-Alzheimers (CNS Preparations)

Indication:
Mild to moderate dementia caused by Alzheimer's or Parkinson's disease.

Dosage & Administration:
Initially, 1.5 mg Capsule twice a day.

Preparation:
Each box contains 20 Capsules in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides